Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

GSK Boosted by Cancer and HIV Drugs as Emma Walmsley Bows Out

Summary by The Independent
Shares in the company rose on Wednesday morning as a result, lifting to their highest level for more than a year.

3 Articles

The IndependentThe Independent
Reposted by
perspectivemedia.comperspectivemedia.com
Lean Left

GSK boosted by cancer and HIV drugs as Emma Walmsley bows out

Shares in the company rose on Wednesday morning as a result, lifting to their highest level for more than a year.

·London, United Kingdom
Read Full Article
EuropaWire.euEuropaWire.eu

GSK Receives EMA Orphan Drug Designation for GSK’227 in Small-Cell Lung Cancer, Strengthening Its ADC Oncology Pipeline

Open the article to view the coverage from EuropaWire.eu

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

EuropaWire.eu broke the news in on Tuesday, October 28, 2025.
Sources are mostly out of (0)

Similar News Topics

Cancer icon

Cancer

Business icon

Business

Belgium icon

Belgium

London, England icon

London, England

UK Economy icon

UK Economy

Belgium Economy icon

Belgium Economy

News
For You
SearchBlindspotLocal